Pharmaceuticals Anonymous

Showing posts with label Obesity. Show all posts
Showing posts with label Obesity. Show all posts

Wednesday, September 15, 2010

Sugar: The Bitter Truth

Ending sugar addiction....an approach that works from a doctor who has had the courage to speak publicly about what is really happening to our food. Fascinating!


Robert H. Lustig, MD

Professor of Clinical Pediatrics, in the Division of Endocrinology Director of the Weight Assessment for Teen and Child Health (WATCH) Program at UCSF

Dr. Lustig is a nationally-recognized authority in the field of neuroendocrinology, with a specific emphasis on the regulation of energy balance by the central nervous system. He is currently investigating the contribution of biochemical, neural, hormonal, and genetic influences in the expression of the current obesity epidemic both in children and adults. He has defined a syndrome of vagally-mediated beta-cell hyperactivity which leads to insulin hypersecretion and obesity, and which is treatable by insulin suppression. This phenomenon may occur in up to 20% of the obese population. He is interested in the hypothalamic signal transduction of insulin and leptin, and how these two systems interact. He is studying the cardiovascular morbidity associated with hyperinsulinemia, and developing methods to evaluate and prevent this phenomenon in children. He is also analyzing the contribution of the autonomic nervous system to insulin secretion and insulin resistance in obese children, and the utility of assessing insulin dynamics in targeting obesity therapy.

Dr. Lustig graduated from MIT, and received his M.D. from Cornell University Medical College. He performed his pediatric residency at St. Louis Children's Hospital, and his clinical fellowship at UCSF. From there, he spent six years as a post-doctoral fellow in neuroendocrinology at The Rockefeller University in New York.

Dr. Lustig has authored over 70 research articles and 35 chapters. He is the Chairman of the Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Obesity Task force of The Endocrine Society, and on the Steering Committee of the International Endocrine Alliance to Combat Obesity.



Sunday, January 31, 2010

Thursday, October 8, 2009

Sunday, June 28, 2009

Psychiatric Treatment: A Risk Factor for Obesity?

Get the stats and facts from the Canadian Pediatric Association (PDF)
https://www.cps.ca/english/Media/NewsReleases/PCHFebruary02/ArticlePsychiatricObesity.pdf or Link

Apparently increased or decreased head size, weight gain and male breast enlargement are pretty common with all antipsychotic medications, and the results can be permanent. Link


Gynecomastia - Man Boobs -

More Americans are taking drugs for mental illness than ever before, reports Reuters.
Why not try food for mood and mental health instead?
An article from the Townsend Letter for Doctors and Patients outlines vitamin treatment of psychosis (schizophrenia) here.